Skip to Content

LCE 200 (Carbidopa, Entacapone and Levodopa 50 mg / 200 mg / 200 mg)

Pill with imprint LCE 200 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 50 mg / 200 mg / 200 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 50 mg / 200 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 200

Carbidopa, Entacapone and Levodopa

Imprint
LCE 200
Strength
50 mg / 200 mg / 200 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-5669 Sandoz Inc.
00078-0527 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Related Images for "LCE 200"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.